Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by TheDudeAbideson Jun 30, 2019 11:31pm
163 Views
Post# 29877760

RE:Tuesday morning...??

RE:Tuesday morning...??When I suggested .30 by end of week it is with the assumption of NR on expected Health Plan agreement. I use .30 based on the fact we already have some of the NR run up in the current SP.

I think if we see no announcement on Tues/Wed (highly unlikely in my opinion), day traders may start to dump with long and new investors picking up the slack. I think worse case senario is we see .14 or .15 again until news received.

I think that there are so many moving parts here (Health Plan, Large Employer Pilot, Aristotle Validation, Q3 Results) that we should have good momentum to maintain upward SP trend through to end of year.

I just think if we get the NR that everyone is expecting that everything should finally start to fall into place for Stage Zero LS.



Bullboard Posts